740 related articles for article (PubMed ID: 12428808)
21. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
22. Role of axonal transport in neurodegenerative diseases.
De Vos KJ; Grierson AJ; Ackerley S; Miller CC
Annu Rev Neurosci; 2008; 31():151-73. PubMed ID: 18558852
[TBL] [Abstract][Full Text] [Related]
23. REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
Tolnay M; Probst A
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):171-87. PubMed ID: 10417659
[TBL] [Abstract][Full Text] [Related]
24. Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly.
Best RL; LaPointe NE; Liang J; Ruan K; Shade MF; Wilson L; Feinstein SC
J Biol Chem; 2019 Aug; 294(33):12265-12280. PubMed ID: 31266806
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.
Kanaan NM; Morfini GA; LaPointe NE; Pigino GF; Patterson KR; Song Y; Andreadis A; Fu Y; Brady ST; Binder LI
J Neurosci; 2011 Jul; 31(27):9858-68. PubMed ID: 21734277
[TBL] [Abstract][Full Text] [Related]
26. Increased acetylation of microtubules rescues human tau-induced microtubule defects and neuromuscular junction abnormalities in
Mao CX; Wen X; Jin S; Zhang YQ
Dis Model Mech; 2017 Oct; 10(10):1245-1252. PubMed ID: 28819043
[TBL] [Abstract][Full Text] [Related]
27. Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease.
Cario A; Berger CL
Bioessays; 2023 Aug; 45(8):e2200138. PubMed ID: 37489532
[TBL] [Abstract][Full Text] [Related]
28. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
Venkatramani A; Panda D
Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
[TBL] [Abstract][Full Text] [Related]
29. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
Sánchez MP; Alvarez-Tallada V; Avila J
Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
[TBL] [Abstract][Full Text] [Related]
30. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
[TBL] [Abstract][Full Text] [Related]
31. Embryonic stem cell-based modeling of tau pathology in human neurons.
Mertens J; Stüber K; Poppe D; Doerr J; Ladewig J; Brüstle O; Koch P
Am J Pathol; 2013 May; 182(5):1769-79. PubMed ID: 23499461
[TBL] [Abstract][Full Text] [Related]
32. Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.
Ballatore C; Brunden KR; Huryn DM; Trojanowski JQ; Lee VM; Smith AB
J Med Chem; 2012 Nov; 55(21):8979-96. PubMed ID: 23020671
[TBL] [Abstract][Full Text] [Related]
33. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.
Higuchi M; Zhang B; Forman MS; Yoshiyama Y; Trojanowski JQ; Lee VM
J Neurosci; 2005 Oct; 25(41):9434-43. PubMed ID: 16221853
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.
Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM
Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192
[TBL] [Abstract][Full Text] [Related]
35. Untangling the Tauopathy for Alzheimer's disease and parkinsonism.
Chang HY; Sang TK; Chiang AS
J Biomed Sci; 2018 Jul; 25(1):54. PubMed ID: 29991349
[TBL] [Abstract][Full Text] [Related]
36. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
[TBL] [Abstract][Full Text] [Related]
37. Tau protein pathology in neurodegenerative diseases.
Spillantini MG; Goedert M
Trends Neurosci; 1998 Oct; 21(10):428-33. PubMed ID: 9786340
[TBL] [Abstract][Full Text] [Related]
38. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.
Götz J; Tolnay M; Barmettler R; Chen F; Probst A; Nitsch RM
Eur J Neurosci; 2001 Jun; 13(11):2131-40. PubMed ID: 11422454
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.
Fujiwara H; Watanabe S; Iwata M; Ueda S; Nobuhara M; Wada-Kakuda S; Misonou H; Miyasaka T
Biochem Biophys Res Commun; 2020 Jan; 521(3):779-785. PubMed ID: 31699369
[TBL] [Abstract][Full Text] [Related]
40. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
Forman MS; Lee VM; Trojanowski JQ
J Chem Neuroanat; 2000 Dec; 20(3-4):225-44. PubMed ID: 11207421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
